We’re super excited we got an ERC Starting Grant to further study patient drug response variability in cancer, using pharmacoscopy and integrative OMICs.
See also the ETHZ press release, and the shout-out we got from 20min.ch!
We’re super excited we got an ERC Starting Grant to further study patient drug response variability in cancer, using pharmacoscopy and integrative OMICs.
See also the ETHZ press release, and the shout-out we got from 20min.ch!